Weekly Newsletter - 10.30.2024

Pfizer CEO Faces Investor Pressure Amid Revenue Challenges

Sales is transforming, but core principles endure. Expert Roderick Jefferson highlights the essentials: hire for cultural fit and adaptability, with AI helping to identify candidates who align with your teamโ€™s needs. Onboarding should be an ongoing journey, including:

  • Company Orientation

  • Role-Specific Training

  • Mentorship from Sales Leaders

Continuous learning keeps teams sharp, with AI personalizing paths for each individual. Data-driven coaching and focusing on meaningful metrics like deal velocity ensure a team built for long-term success.

For more insights, download the ebook, a partnership with Hive Perform and Roderick Jefferson.

INDUSTRY INSIGHTS ๐ŸŒ

AI is revolutionizing medicine creation, akin to electricity's transformative impact. Despite high failure rates in drug development, AI offers potential cost savings and efficiency. The biopharma industry's slow AI adoption is due to mindset challenges and high margins, but understanding AI's application is crucial for progress and innovation.

INDUSTRY NEWS ๐Ÿ“ฐ

HCA Healthcare is collaborating with Commure to develop an ambient AI platform aimed at enhancing healthcare delivery. This multi-specialty, EHR-agnostic system will improve workflows in emergency and ambulatory care, boosting physician productivity and patient care quality. The initiative reflects HCA's commitment to integrating AI into healthcare.

AbbVie has acquired Aliada Therapeutics to enhance its R&D in Alzheimer's treatment. The acquisition includes ALIA-1758, an antibody targeting amyloid beta plaques, using Aliada's MODEL platform for blood-brain barrier crossing. This move aims to advance therapies for neurological disorders, addressing critical unmet needs in Alzheimer's disease.

Activist investor Starboard Value challenges Pfizer CEO Albert Bourla, citing underperformance. Analysts support Bourla, noting his cost-cutting and growth efforts. Despite Starboard's criticism, analysts believe management changes won't quickly resolve issues. Pfizer's Q3 outlook is positive, with potential upside in COVID-19 product demand and earnings projections.

EVENTS ๐Ÿ“†

Join sales enablement expert Roderick Jefferson from @Roderick Jefferson & Associates as he explores "Ever-Boarding" -- a continuous process for developing and upskilling sales professionals.

Date and Time: Nov 13th (Wednesday), 2 PM ET / 6 PM GMT

You'll learn:

โ–  How AI can help you provide personalised coaching to sales reps based on their individual strengths and weaknesses, analysing calls, emails, and meetings to identify areas for improvement

โ–  How to build a culture of continuous learning and development by using AI-powered tools to deliver knowledge bites and reinforce best practices

โ–  How to design a data-based process that removes time blockers and accelerates the ramping up of sales reps

๐Ÿ”— Register now!

Sales Intelligence is a Contentive publication in the Sales & Marketing division